INTRODUCTION
============

CNG channels are known for their essential contribution to sensory transduction in photoreceptors and olfactory sensory neurons, and for their expression in other diverse cell types where their physiological actions are less well defined ([@bib40]; [@bib8]). Six genes in mammals encode pore-forming CNG channel subunits: CNGA1 (A1), A2, A3, A4, B1, and B3. Each subunit presents cytoplasmic N- and C-terminal regions, a conserved pore domain, a vestigial voltage-sensor domain homologous to that of related voltage-gated channels, and an intracellular cyclic nucleotide-binding (CNBD) domain. Ligand binding (cyclic guanosine monophosphate \[cGMP\] or cAMP) to one or more of these intracellular sites is coupled to opening of the channel pore. Native CNG channels are formed by the assembly of some combination of these subunits in a tetrameric complex, generating channels with properties optimized for the role they play in specific cell types ([@bib40]; [@bib13]). The principal rod photoreceptor, olfactory receptor, and cone photoreceptor CNG channels are composed of 3A1:B1 ([@bib80]; [@bib88]; [@bib91]), 2A2:A4:B1b ([@bib87]), or 2A3:2B3 subunits ([@bib60]; but see also [@bib16]), respectively. The B1, A4, and B3 subunits alone cannot form functional homomeric channels, but commonly modify ligand sensitivity and channel regulation properties in heteromeric channels.

CNG channel activity can be modulated by diverse intracellular messengers, including calcium feedback via calmodulin (CaM) or related calcium sensor proteins ([@bib35]; [@bib49]; [@bib26]; [@bib69]; [@bib76]; [@bib5]; [@bib64]; [@bib65]), serine/threonine and tyrosine-phosphorylation events ([@bib24]; [@bib54]; [@bib9]), and lipid signaling molecules such as diacylglycerol and phosphoinositides ([@bib25]; [@bib82]; [@bib11]; [@bib85]; [@bib6]; [@bib7]). These adjustments of CNG channel ligand sensitivity are thought to be integral to several important physiological processes, including but not limited to olfactory receptor and photoreceptor adaptation ([@bib45]; [@bib17]), and paracrine and circadian control of photoreceptor sensitivity ([@bib42], [@bib43]; [@bib10]). In general, the control of ion channel activity by phosphoinositides has emerged recently as a nearly universal feature of many different classes of channels. For most channels, activity is supported or potentiated by phosphoinositides, particularly phosphatidylinositol (4,5)-biphosphate (PIP~2~; [@bib72]). Phosphoinositides such as PIP~2~ or phosphatidylinositol (3,4,5)-trisphosphate (PIP~3~) have been shown to inhibit the activity of native and recombinant rod ([@bib82]), cone ([@bib82]; [@bib7]), and olfactory ([@bib71]; [@bib6]) CNG channels. For example, the ligand sensitivity of A3+B3 channels is sensitive to manipulations of endogenous phosphoinositides using chemical or pharmacological tools, as well as direct application of phosphoinositides to inside-out patches ([@bib7]). With the exception of the olfactory channel ([@bib6]), little is known about the molecular mechanisms underlying regulation of CNG channels by phosphoinositides. For olfactory CNG channels, the N-terminal region of CNGA2 subunits is necessary for regulation by PIP~3~, most likely by providing a phosphoinositide-binding site. Moreover, PIP~3~ binding to A4 and B1b subunits attenuates CaM regulation of olfactory CNG channels ([@bib6]), which suggests a functional interaction between different regulatory pathways. For photoreceptor CNG channels, the specific subunits, structural elements, and interactions that mediate phosphoinositide control have remained unanswered questions.

In this paper, we have investigated mechanisms supporting regulation of cone photoreceptor CNG channels by phosphoinositides using heterologous expression of channel subunits, electrophysiology, and molecular manipulations. Here we have identified features within CNGA3 subunits that are necessary for inhibition by PIP~2~ or PIP~3~. Our results suggest that regulation is mediated by two structural components, located within the cytoplasmic N- and C-terminal domains of CNGA3, respectively. These two separable components have divergent effects on gating of homomeric channels, but both contribute to the PIP~n~-induced change in cGMP apparent affinity for heteromeric CNGA3+CNGB3 channels. In addition, we find that complementary combinations of PIP~n~-insensitive subunits can reconstitute regulation, which is consistent with intersubunit coupling between these N- and C-terminal regions.

MATERIALS AND METHODS
=====================

DNA and mutagenesis
-------------------

Human CNGB3 was cloned as described previously ([@bib58]). Human CNGA3 was a gift of K.-W. Yau (Johns Hopkins University, Baltimore, MD). Bovine CNGA1, rat CNGA2, and human CNGB1 were generously provided by W. Zagotta (University of Washington, Seattle, WA). Subunit cDNAs were subcloned into pGEMHE, where they are flanked by the *Xenopus laevis* β-globin gene 5′ and 3′ untranslated regions (UTRs), for heterologous expression in *X. laevis* oocytes. Point mutations were generated by overlapping PCR (cassette) mutagenesis. All mutations were confirmed by fluorescence-based DNA sequencing. Concatenated cDNA constructs were generated as described previously, where the stop codon for the leading subunit and the start codon for the trailing subunit were replaced by a short linker sequence (IAGGGGGRARLPA), combining the coding sequences for the two subunits in a single open reading frame ([@bib60]). Previous studies using A3//A3 dimers ([@bib60]) suggest that the linker has only a slight effect on the activation properties of the channels. The cDNA and transcribed complimentary RNA (cRNA) of the tandem--dimer constructs were checked for recombination by agarose gel electrophoresis.

PIP~3~-binding assays
---------------------

Recombinant GST fusion protein expression in bacteria and lipid interaction assays were performed as described previously ([@bib58]; [@bib6]). After purification, soluble GST fusion proteins were isolated after centrifugation at 20,000 *g* and 4°C for 30 min to remove insoluble material. GST fusion proteins were then used for in vitro PIP~3~-binding assays in buffer containing 10 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM EDTA, 0.25% vol/vol Triton X-100, and 0.25% vol/vol Nonidet P-40. PIP~3~-agarose beads were from Echelon Biosciences. In brief, 40 µl of a 50% slurry of PIP~3~ or control agarose beads and purified protein (2 µg/ml) was incubated in 0.5 ml of binding buffer for 2 h at 4°C with rocking. Beads were gently pelleted and washed five times with excess binding buffer; PIP~3~-interacting proteins were eluted with 1× NuPAGE sample buffer (Invitrogen). Protein samples then were separated under reducing conditions in 4--12% Bis-Tris gels and blotted onto nitrocellulose by using the NuPAGE transfer buffer system (Invitrogen). Blotted proteins were detected overnight by using B-14 anti-GST monoclonal antibody (Santa Cruz Biotechnology, Inc.) at a dilution of 1:2,000 in 1% milk, 500 mM NaCl, 20 mM Tris-HCl (pH 7.5), and 0.05% Tween 20. Anti-actin antibody (EMD Millipore) was used to ensure the same amount of input protein was used. Horseradish peroxide--conjugated anti--mouse IgG secondary antibodies were used subsequently for 1 h. Chemiluminescent detection was performed using the Super-Signal West Dura Extended Duration substrate chemiluminescence detection kit (Thermo Fisher Scientific).

Electrophysiology
-----------------

For expression in *X. laevis* oocytes, channel subunit cDNAs were linearized by digestion with NheI or SphI, and cRNA was synthesized in vitro using an upstream T-7 promoter (mMessage mMachine; Ambion). Stage IV oocytes were isolated as described previously ([@bib79]). The animal-use protocols were consistent with the recommendations of the American Veterinary Medical Association and were approved by the Institutional Animal Care and Use Committee (IACUC) of Washington State University. Approximately 20 ng of channel RNA was microinjected per oocyte; to efficiently generate heteromeric channels, an excess of B subunit RNA relative to A subunit RNA was injected ([@bib60]). 2--7 d after microinjection of in vitro transcribed cRNA into oocytes, patch-clamp experiments were performed using an Axopatch 200B amplifier (Molecular Devices) in the inside-out configuration. Recordings were made at 20--22°C. Initial pipette resistances were 0.30--0.80 Mohm. Intracellular (bath) and extracellular (pipette) solutions contained 130 mM NaCl, 0.2 mM EDTA, and 3 mM Hepes, pH 7.2. Cyclic nucleotides were added to intracellular solution as needed. Intracellular solutions were changed using an RSC-160 rapid solution changer (Molecular Kinetics). For Ca^2+^-CaM experiments, 250 nM CaM was used in intracellular solution containing 130 mM NaCl, 3 mM Hepes, pH 7.2, 3.6 mM CaCl~2~, and 10 mM hydroxyethyl ethylenediaminetriacetic acid (HEDTA), for a final \[Ca^2+^\] of 2 µM. 500 µM niflumic acid was added to the pipette solution for Ca^2+^-CaM experiments. PIP~n~ solutions were prepared with FVPP (a phosphatase inhibitor cocktail; [@bib36]) containing 5 mM sodium fluoride, 0.1 mM sodium orthovanadate, and 10 mM sodium pyrophosphate, as described previously ([@bib7]); FVPP seems to stabilize PIP~n~ effects and slow reversal during washout ([@bib7]). PIP~3~ and PIP~2~ analogues were PIP~3~, dipalmitoyl, sodium salt and PIP~2~, dipalmitoyl, sodium salt (Matreya LLC). Natural brain PIP~2~ was from Avanti Polar Lipids, Inc. Poly-lysine and cytochalasin D (cyto D) were obtained from Sigma-Aldrich.

Data analysis
-------------

Data were acquired and analyzed using Pulse (HEKA), Igor (WaveMetrics), and SigmaPlot/SigmaStat (Systat Software). Currents in the absence of cyclic nucleotide were subtracted. For channel activation by cyclic nucleotides, dose--response data were fitted with the Hill equation, I/I~max~ = \[cNMP\]*^h^*/(K~1/2~*^h^* + \[cNMP\]*^h^*), where I is the current amplitude at +80 mV, I~max~ is the maximum current elicited by a saturating concentration of the ligand, \[cNMP\] is the ligand concentration, K~1/2~ is the concentration of cNMP producing half-maximal current, and *h* is the Hill coefficient. For the [l]{.smallcaps}-cis-diltiazem (Sigma-Aldrich) experiments, 1 mM cGMP was used at +80 mV with or without 25 µM [l]{.smallcaps}-cis-diltiazem in the intracellular solution to confirm the formation of heteromeric CNG channels.

The Gibbs free energy, ΔG, of the overall reaction of CNG channel opening was calculated using the following equation, which assumed that the number of cGMP ligands contributing to the channel activation was designated by the Hill coefficient ([@bib14]; [@bib46]), ΔG = −RT*ln*(1/K~1/2~*^h^*), where R is the gas constant, 1.987 cal·K^−1^ · mol^−1^, and T is the temperature (298 K). Based on that equation, we calculated the phosphoinositide-induced energy change for the channel opening reaction, ΔΔG, using ΔΔG = ΔG~PIPn~ − ΔG~cont~ = RT*ln*\[(K~1/2,PIPn~*^h(PIPn)^*)/(K~1/2,cont~*^h(cont)^*)\], where cont (control) and PIP~n~ indicate the values before and after phosphoinositide treatment. Data parameters were expressed as mean ± SEM of *n* experiments unless otherwise indicated. Statistical significance was determined by using Student's *t* test (or a Mann--Whitney *U* test). For comparing multiple groups of experiments, one-way analysis of variance followed by all pairwise multiple comparisons (Tukey's test for the multiple comparisons) was applied; a P-value of \<0.05 was considered significant.

We used fluctuation analysis to estimate P~o\ max~ at saturation concentrations of cyclic nucleotide. Mean isochrone variances (σ^2^) from 4--8 sweeps at a low and saturating concentration of cyclic nucleotide were calculated, respectively ([@bib2]). Currents were low-pass filtered at 2 kHz and digitized at 25 kHz. Assuming binomial distribution, P~o\ max~ was calculated using the following equation ([@bib28]): P~o\ max~ = 1 -- (σ~max~^2^/I~max~)/(σ~low~^2^/I~low~), where σ~max~^2^ and σ~low~^2^ are mean isochrone variances at saturating and low concentrations of cyclic nucleotides, respectively; I~max~ and I~low~ are mean macroscopic currents at corresponding concentrations of cyclic nucleotides. The P~o\ max~ for cAMP was calculated based on P~o\ max~ for cGMP multiplied by I~max~ cAMP/cGMP.

In addition, we used tetracaine, a known state-dependent blocker of CNG channels, to estimate the P~o\ max~. Tetracaine binds to closed channels with nearly 1,000-fold greater affinity compared with open channels; thus, channels that spend more time in the open state are less sensitive to tetracaine block ([@bib20]). As described previously ([@bib20]; [@bib48]), we calculated the equilibrium constant for the allosteric transition (L) for cGMP-bound channels using the apparent affinity for tetracaine (K~1/2,tetracaine~) and the following equation: L~cG~ = K~do~(K~1/2,tetracaine~ − K~dc~)/K~dc~(K~do~ − K~1/2,tetracaine~).

In this equation, *K*~dc~ (220 nM) and *K*~do~ (170 µM) are dissociation constants for tetracaine binding to closed or open channels, respectively. P~o\ max~ was calculated as P~o\ max~ = L/(1 + L). The P~o\ max~ for cAMP was also calculated using P~o\ max~ for cGMP and I~max~ cAMP/cGMP.

Online supplemental material
----------------------------

Fig. S1 shows the effects of PIP~n~ on apparent cGMP affinity of homomeric CNGA1, CNGA2, and CNGA3 channels. Fig. S2 shows that disruption of the cytoskeleton by cyto D does not prevent PIP~3~ regulation of cAMP efficacy for homomeric CNGA3 channels. Fig. S3 shows several CNGB3 truncations and mutations that do not prevent PIP~n~ regulation of CNGA3+CNGB3 channels. Online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201210944/DC1>.

RESULTS
=======

C-terminal component for regulation of CNGA3 channels by phosphoinositides
--------------------------------------------------------------------------

To investigate the mechanisms responsible for regulation of cone CNG channels by phosphoinositides, we expressed human CNGA3 subunits alone or with human CNGB3 subunits in *X. laevis* oocytes. For photoreceptor CNG channels, cGMP is nearly a full agonist, whereas cAMP is a partial agonist; this difference in efficacy for cAMP and cGMP depends on how well the bound ligands are able to promote the allosteric conformational change associated with channel opening ([@bib28]; [@bib23]; [@bib79]). We evaluated the relative efficacy of cAMP versus cGMP by measuring the current at +80 mV elicited by saturating concentrations of the respective ligands (10 mM for cAMP, 1 mM for cGMP). Although the apparent cGMP affinity of homomeric CNGA3 channels was not significantly altered by PIP~3~ ([@bib6]) or PIP~2~ (Fig. S1), we surprisingly observed that application of phosphoinositide analogues to the cytoplasmic face of excised inside-out patches produced a large increase in the maximal cAMP current. We found that 1 µM diC8-PI (3, 4, 5) P~3~ (PIP~3~) or 10 µM diC8-PI (4, 5) P~2~ (PIP~2~) elicited a similar increase in relative cAMP efficacy ([Fig. 1, A and B](#fig1){ref-type="fig"}; for simplicity, in subsequent text and figures diC8-PI (3, 4, 5) P~3~ and diC8-PI (4, 5) P~2~ are referred to as PIP~3~ and PIP~2~, respectively). Reversal of this effect was facilitated by 25 µg/ml poly-lysine ([Fig. 1, A and B](#fig1){ref-type="fig"}), which screens the negative charges of the phosphoinositides. Similar results were observed with application of a 10-fold higher concentration of PIP~3~ (10 µM; fold increase in I~max~ cAMP/cGMP was 2.63 ± 0.13, *n* = 4) or with application of 10 µM natural PIP~2~ (fold increase in I~max~ cAMP/cGMP was 2.24 ± 0.26, *n* = 4). The maximal cGMP current for homomeric CNGA3 channels was not significantly altered by PIP~3~ or PIP~2~ (P = 0.463 for PIP~3~, P = 0.437 for PIP~2~). In contrast, for CNGA1 homomeric channels, PIP~3~ or PIP~2~ decreased relative cAMP efficacy ([Fig. 1 C](#fig1){ref-type="fig"}), which is consistent with the general inhibitory effect of these phosphoinositides on CNGA1 channel gating ([Fig. S1](http://www.jgp.org/cgi/content/full/jgp.201210944/DC1){#supp1}). In addition, neither PIP~3~ nor PIP~2~ significantly altered the apparent cAMP affinity of homomeric CNGA3 channels (P \> 0.05); K~1/2~ cAMP was found to be 1.13 ± 0.02 mM (*n* = 8) before PIP~n~ application, 1.16 ± 0.06 mM (*n* = 4) after PIP~3~, and 1.13 ± 0.04 mM (*n* = 4) after PIP~2~. Endogenous phosphoinositides also may tune cAMP efficacy of CNGA3 channels: application of poly-lysine to control patches produced a small but significant decrease in I~max~ cAMP/cGMP, from 0.18 ± 0.01 before to 0.10 ± 0.01 after poly-lysine (*n* = 4; P \< 0.05). For heteromeric CNGA3+CNGB3 channels, no significant change in cAMP efficacy was observed with exposure of membrane patches to PIP~3~ and PIP~2~ (I~max~ cAMP/cGMP was 0.27 ± 0.01 \[*n* = 11\] before PIP~n~ application, 0.27 ± 0.02 \[*n* = 6\] after PIP~2~, and 0.30 ± 0.03 \[*n* = 5\] after PIP~3~). Together, these results show that CNGA3, in the absence of CNGB3 subunits, exhibits a PIP~n~-induced increase in cAMP efficacy.

![PIP~3~ or PIP~2~ potentiates relative cAMP efficacy for homomeric CNGA3 channels. (A) Representative current traces for homomeric CNGA3 channels, elicited by saturating concentrations of cGMP (1 mM, green) or cAMP (10 mM, red), before and after 1 µM PIP~3~ (diC8-PIP~3~) application, and after subsequent application of 25 µg/ml poly-lysine (poly-K). Currents were elicited by voltage steps from a holding potential of 0 mV to +80 mV, then to −80 mV and 0 mV (inset). Leak currents in the absence of cyclic nucleotide were subtracted. The arrowhead indicates I~max~ elicited by cAMP in the presence of PIP~3~. (B) Time course for the change in maximal cAMP current (in 10 mM cAMP) induced by 1 µM PIP~3~; also shown is reversal by 25 µg/ml poly-K. Horizontal bars indicate application of respective agents; currents were not recorded during poly-K application. (C) Summary illustrating PIP~3~ (diC8-PIP~3~)- or PIP~2~ (diC8-PIP~2~)-dependent changes in I~max~ cAMP/cGMP for CNGA3 and CNGA1 homomeric channels (normalized to control values before treatment). Data are from 10--12 (for PIP~3~) or 3--4 (for PIP~2~) independent experiments; \*, P \< 0.05 relative to before PIP~n~ application (control). The broken horizontal line refers to normalization to the value for I~max~ cAMP/cGMP of control patches. Error bars indicate mean ± SEM.](JGP_201210944_Fig1){#fig1}

For CNG channels and hyperpolarization-activated CNG (HCN) channels, one key structural feature that contributes to cyclic-nucleotide selectivity and efficacy is a critical residue (D604 in CNGA1, D609 in CNGA3, and I636 in HCN2) within the Cα helix of the CNBD ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib79]; [@bib60]; [@bib19]; [@bib93]). Although other structural features in CNG channels can impart ligand-specific effects on gating ([@bib83]), this aspartic acid residue in CNGA1 is thought to interact more favorably with cGMP, while presenting a repulsive electrostatic interaction with cAMP, during the opening allosteric transition ([@bib79]; [@bib73]). Using fluctuation analysis, we estimated the absolute P~o\ max~ for wild-type CNGA3 channels in saturating concentrations of cGMP and cAMP to be 0.97 ± 0.01 (*n* = 10) and 0.13 ± 0.01 (*n* = 10), respectively. These P~o\ max~ values for CNGA3 were similar to those obtained using a state-dependent block by tetracaine ([@bib20]; [@bib48]): ∼0.99 and ∼0.12, respectively. Fluctuation analysis confirmed that PIP~3~ increased the absolute P~o\ max~ cAMP to 0.37 ± 0.07 (*n* = 4), without significantly altering P~o\ max~ cGMP (0.93 ± 0.01; *n* = 4). To determine whether the PIP~n~-induced change in cAMP efficacy may involve changes in the interaction between cAMP and D609 in CNGA3, we altered this side chain via site-directed mutagenesis. As previously demonstrated ([@bib60]), the D609K mutation increased relative cAMP efficacy (I~max~ cAMP/cGMP for D609K: 0.31 ± 0.02, *n* = 13) compared with wild-type channels (I~max~ cAMP/cGMP for wild-type CNGA3: 0.15 ± 0.01, *n* = 20; P \< 0.001). For D609K channels, absolute P~o\ max~ was estimated (using tetracaine block) to be 0.78 ± 0.01 (*n* = 7) for cGMP and 0.27 ± 0.02 (*n* = 7) for cAMP. D609K eliminated the PIP~n~-dependent increase in cAMP efficacy for homomeric CNGA3 channels ([Fig. 2, B and C](#fig2){ref-type="fig"}). Furthermore, mutation D609M in CNGA3, similar to the equivalent CNGA1 D604M ([@bib79]), reversed ligand selectivity for homomeric CNGA3 channels, making cAMP a better agonist than cGMP (I~max~ cAMP/cGMP for D609M: 2.83 ± 0.16, *n* = 4). For D609M channels, absolute P~o\ max~ was estimated (using tetracaine block) to be 0.81 ± 0.02 (*n* = 9) for cAMP and 0.30 ± 0.02 (*n* = 9) for cGMP. Interestingly, PIP~3~ elevated relative cGMP efficacy for D609M channels ([Fig. 2, B and C](#fig2){ref-type="fig"}), the inverse of the increase in cAMP efficacy observed for wild-type CNGA3 ([Fig. 1 A](#fig1){ref-type="fig"}). Together, these results show that PIP~n~ can produce ligand-specific effects on channel gating, potentiating the ability of partial agonists to promote channel opening. The results are consistent with the interpretation that PIP~n~ can alter interactions between the channel and cyclic nucleotides during the conformational changes associated with channel opening.

![Mutation of critical ligand-discrimination residue (D609) within CNGA3 alters the PIP~3~-induced increase in relative cAMP efficacy. (A) Diagram illustrating the basic topology of CNGA3 subunits (green), which are comprised of six transmembrane domains, with N- and C-terminal regions located on the intracellular side of the membrane. The light green cylinder represents the Cα helix of the CNBD. The asterisk indicates a critical ligand-discrimination residue, aspartic acid at position 609 (D609) within the CNBD. (B) Representative current traces elicited by 1 mM cGMP (green) or 10 mM cAMP (red) before and after 1 µM PIP~3~, for CNGA3 D609K and D609M channels. The arrowhead indicates I~max~ elicited by cGMP in the presence of PIP~3~. (C) Summary of the effects of 1 µM PIP~3~ on the current elicited by saturating cAMP or cGMP, for CNGA3 wild-type, D609K, or D609M channels; \*, P \< 0.05 compared with wild-type channels, *n* = 4--5. The broken horizontal line refers to a ratio of one, equivalent to no change in the parameter after PIP~n~ application. Error bars indicate mean ± SEM.](JGP_201210944_Fig2){#fig2}

Another important aspect of CNG channel ligand selectivity and for coupling the conformational change in the CNBD to channel opening is reorientation of the Cα helix ([@bib79]; [@bib51]; [@bib50]; [@bib19]; [@bib74]). We reasoned that the C-terminal region of the channel immediately distal to the Cα helix might play a role in mediating the effect of phosphoinositides on cAMP efficacy by influencing this reorientation. To test this idea, we generated serial deletions of the C-terminal region of CNGA3 ([Fig. 3 A](#fig3){ref-type="fig"}). Truncation of CNGA3 after amino acid 674 (675X) preserved the PIP~3~-induced change in cAMP efficacy ([Fig. 3 B](#fig3){ref-type="fig"}). However, A3-655X channels exhibited less sensitivity to PIP~3~, and A3-635X and A3-613X channels failed to show a PIP~3~-dependent increase in cAMP efficacy ([Fig. 3 B](#fig3){ref-type="fig"}). For A3-635X, even a 10-fold higher concentration of PIP~3~ (10 µM) produced no significant increase in cAMP efficacy (fold change after PIP~3~ was 1.06 ± 0.03, *n* = 4; P = 0.799 compared with before PIP~3~). The truncations alone produced only minor effects on the basic gating properties of CNGA3 channels ([Table 1](#tbl1){ref-type="table"}), which cannot easily account for the loss of PIP~n~ sensitivity. These results show that the PIP~n~-mediated change in relative cAMP efficacy requires the post-CNBD region of CNGA3, including residues located between 635 and 655.

![Change in relative cAMP efficacy after PIP~3~ is dependent on the C-terminal region of CNGA3. (A) Schematic diagram showing sites of truncations and charge neutralizations within the human CNGA3 C-terminal region, and a sequence alignment of this region with orthologous CNGA3 proteins (canine, mouse, bovine, and gallus). Seven conserved lysines and arginines are highlighted in yellow. Bold nucleotides indicate residues in human A3 that were mutated in our study as well as related residues in A3 orthologues. The numbers above the sequence alignment indicate sites for introduced channels. Green highlighting indicates the distal region of the Cα helix. The asterisk indicates D609, as described in [Fig. 2](#fig2){ref-type="fig"}. (B) Representative current traces (left), elicited by 1 mM cGMP (green) or 10 mM cAMP (red) before and after 1 µM PIP~3~, for CNGA3 675X and 635X channels. The right panel summarizes the effects of CNGA3 C-terminal deletions on PIP~3~-induced increases in cAMP efficacy; \*, P \< 0.05 compared with wild-type channels, *n* = 4--9. The arrowhead indicates I~max~ elicited by cAMP in the presence of PIP~3~. (C) Representative current traces (left), elicited by 1 mM cGMP (green) or 10 mM cAMP (red) before and after 1 µM PIP~3~, for A3 C7K/R-A (K624A, K629A, R643A, R646A, K657A, K659A, R661A) and RR-QQ (R643Q, R646Q) channels. The right panel summarizes effects of mutations within the A3 C-terminal region on PIP~3~-induced increases in cAMP efficacy; \*, P \< 0.05 compared with wild-type channels, *n* = 4--6. The broken horizontal lines refer to a ratio of one, equivalent to no change in the parameter after PIP~n~ application. (D) In vitro pull-down assay using PIP~3~-bound or control agarose beads combined with GST fusion proteins representing the C-terminal region of CNGA3. Input proteins (bottom) and bound proteins (top) were identified by immunoblotting with anti-GST antibodies. A3C, C-terminal region of human CNGA3 from amino acids 612--694; A3C7K/R-A, C-terminal region with seven lysines and arginines neutralized to alanines, as highlighted in A; A3C-635X, C-terminal region of CNGA3 truncated at amino acid 635. Molecular weight markers (in kilodaltons) are shown on the left. Data are representative of four independent experiments. Error bars indicate mean ± SEM.](JGP_201210944_Fig3){#fig3}

###### 

Gating parameters for CNGA3 mutations

  CNGA3               K~1/2~ cGMP (µM)                                     Hill coefficient   P~o\ max~ cGMP     I~max~ cAMP/I~max~ cGMP
  ------------------- ---------------------------------------------------- ------------------ ------------------ ---------------------------------------------------
  Wild type           9.29 ± 0.43 (18)                                     1.91 ± 0.04 (18)   0.97 ± 0.01 (10)   0.14 ± 0.01 (20)
  613X                12.68 ± 0.99 (11)[a](#tblfn1){ref-type="table-fn"}   1.55 ± 0.09 (11)   0.93 ± 0.01 (4)    0.12 ± 0.01 (16)
  635X                8.20 ± 0.57 (5)                                      2.00 ± 0.00 (5)    0.92 ± 0.01 (4)    0.18 ± 0.02 (5)
  655X                8.83 ± 0.26 (3)                                      1.73 ± 0.10 (3)    0.94 ± 0.01 (4)    0.15 ± 0.02 (4)
  675X                9.22 ± 0.55 (4)                                      1.88 ± 0.05 (4)    ND                 0.15 ± 0.02 (6)
  C7K/R-A             9.37 ± 0.29 (6)                                      2.00 ± 0.00 (6)    0.92 ± 0.01 (4)    0.16 ± 0.01 (6)
  RR-QQ               7.45 ± 0.63 (3)                                      2.00 ± 0.00 (3)    0.94 ± 0.01 (3)    0.15 ± 0.01 (13)
  RR-EE               8.29 ± 0.47 (4)                                      1.95 ± 0.05 (4)    0.93 ± 0.03 (4)    0.17 ± 0.01 (10)
  P99L, A105P         5.30 ± 0.18 (7)[a](#tblfn1){ref-type="table-fn"}     2.00 ± 0.00 (7)    0.95 ± 0.01 (4)    0.21 ± 0.01 (7)[a](#tblfn1){ref-type="table-fn"}
  ΔN (2-156)          9.16 ± 0.65 (9)                                      1.77 ± 0.07 (9)    ND                 0.18 ± 0.01 (13)[a](#tblfn1){ref-type="table-fn"}
  ΔN (2-156), 613X    15.75 ± 2.80 (6)[a](#tblfn1){ref-type="table-fn"}    1.66 ± 0.10 (6)    ND                 0.10 ± 0.02 (6)
  ΔN (51-107), 613X   11.14 ± 2.28 (4)                                     1.90 ± 0.06 (4)    ND                 0.10 ± 0.01 (4)
  N7R-A               8.89 ± 1.15 (4)                                      1.59 ± 0.18 (4)    ND                 0.11 ± 0.01 (4)
  N7R-A, 613X         16.36 ± 1.65 (6)[a](#tblfn1){ref-type="table-fn"}    1.82 ± 0.04 (6)    ND                 0.10 ± 0.04 (4)
  N5R-A, 613X         16.74 ± 0.98 (8)[a](#tblfn1){ref-type="table-fn"}    1.71 ± 0.05 (8)    ND                 0.10 ± 0.01 (8)
  N2R-A, 613X         16.10 ± 0.59 (4)[a](#tblfn1){ref-type="table-fn"}    1.68 ± 0.03 (4)    ND                 0.11 ± 0.01 (4)

The numbers in parentheses after the gating parameters indicate the number of patches (*n*).

Significant difference compared to wild-type CNGA3 channels (P \< 0.05).

Phosphoinositides may regulate CNGA3 agonist efficacy through several possible mechanisms. For some channels, channel-interacting proteins appear to confer sensitivity to PIP~n~ regulation via an indirect mechanism. For other channels, poly-basic motifs present in cytoplasmic regions have been shown to be necessary for PIP~n~ regulation of channel function, possibly because they form direct electrostatic interactions with phosphoinositides or because they indirectly help couple PIP~n~ binding to changes in channel gating (for reviews see [@bib21]; [@bib68]; [@bib72]). Given the precedent provided by other channels, we hypothesized that conserved positively charged residues located in the post-CNBD region of CNGA3 may play a role in PIP~n~ regulation of cAMP efficacy. To test this idea, we generated mutations of these residues and investigated the effect of the mutations on PIP~n~ sensitivity. Neutralization of seven conserved lysines or arginines (C7K/R-A: K624A, K629A, R643A, R646A, K657A, K659A, R661A) within the C-terminal region of CNGA3 attenuated the PIP~3~-induced change in cAMP efficacy ([Fig. 3 C](#fig3){ref-type="fig"}); these charge neutralizations did not significantly alter basic channel gating properties compared with wild-type CNGA3 ([Table 1](#tbl1){ref-type="table"}). Neutralization of the three positively charged residues located between 655 and 675 (C3K/R-A: K657A, K659A, R661A) had no significant effect on the change in cAMP efficacy with PIP~3~. Furthermore, neutralization of the two arginines located between 635 and 655 (RR-QQ: R643Q and R646Q) eliminated the PIP~3~-induced increase in cAMP efficacy ([Fig. 3 C](#fig3){ref-type="fig"}). Somewhat paradoxically, charge reversal at these positions (RR-EE: R643E and R646E) reduced but did not eliminate the PIP~3~-induced increase in cAMP efficacy, possibly because of more global changes in the structure of this region (see [@bib34]). These results show that conserved residues R643 and R646 in CNGA3 play a role in mediating the PIP~n~-dependent increase in cAMP efficacy. It is also likely that other structural features in the C-terminal region are necessary for PIP~n~ sensitivity.

One possible mechanism for the PIP~n~-induced increase in cAMP efficacy is direct binding to the C-terminal region of the channel. To test for a potential direct channel--PIP~n~ interaction, we used a pull-down assay with PIP~3~-linked agarose beads in combination with recombinant channel fragments expressed in *Escherichia coli* and subsequently purified using GST tags. This approach is not quantitative, and is not expected to accurately reflect conditions present at the plasma membrane with intact channels. In vitro PIP~3~ binding was observed for the C-terminal channel fragment (A3C) containing amino acids 612--694 ([Fig. 3 D](#fig3){ref-type="fig"}). In addition, no binding was observed for control beads under these conditions. Charge neutralization of the conserved lysines and arginines in this region (A3C7K/R-A) or the 635X truncation (A3C-635X) both attenuated binding to PIP~3~ beads. Collectively, these data imply that structural elements within the C-terminal region of CNGA3 are necessary for a component of PIP~n~ regulation. Also, the C-terminal region appears to be capable of supporting PIP~3~ binding, at least in vitro. However, some caution is required for the interpretation of in vitro PIP~n~-binding studies; other indirect mechanisms remain possible explanations for the C-terminal component of PIP~n~ action on the channel.

A plausible indirect mechanism for the link between phosphoinositides and the C-terminal region of CNGA3 is the cytoskeleton ([@bib15]; also see, for example, [@bib57]). We found that application of 10 µM cyto D, an agent that disrupts the actin-based cytoskeleton, to inside-out patches produced a decrease in cAMP efficacy for homomeric CNGA3 channels ([Fig. S2, A and B](http://www.jgp.org/cgi/content/full/jgp.201210944/DC1){#supp2}). Truncation of the C-terminal region of CNGA3 (613X) mimicked and prevented further gating changes by cyto D (Fig. S2, A and B). This difference between wild-type and 613X channels suggests that deletion of the C-terminal region of CNGA3 uncouples the channel from the cytoskeleton. However, when we examined the effect of cyto D on the PIP~3~ sensitivity of wild-type CNGA3, prior application of cyto D did not significantly alter the PIP~3~-induced increase in relative cAMP efficacy (fold increase I~max~ cAMP/cGMP was 2.54 ± 0.27, *n* = 10; P = 0.307 compared with no cyto D; Fig. S2 C). Therefore, despite the convergent requirement for an intact C-terminal region for both the PIP~n~- and cyto [d]{.smallcaps}--mediated changes in cAMP efficacy, the C-terminal component of PIP~n~ regulation is not prevented by disruption of the actin cytoskeleton, which suggests that a connection with the cytoskeleton is not required.

The cytoplasmic N-terminal region of CNGA3 supports PIP~n~-dependent change in apparent cGMP affinity when unmasked by C-terminal truncation
--------------------------------------------------------------------------------------------------------------------------------------------

How is the PIP~n~-dependent change in apparent cGMP affinity for heteromeric CNGA3+CNGB3 channels mediated? Helping to address this question, we found that C-terminal truncation of CNGA3 after the CNBD (A3-613X) produced homomeric channels that exhibited a large increase in K~1/2~ cGMP after PIP~3~ application ([Fig. 4, B and C](#fig4){ref-type="fig"}). Enhanced PIP~n~ sensitivity was not observed after a less extensive C-terminal truncation (A3-635X). For A3-613X channels, the change in apparent cGMP affinity with phosphoinositides was analogous to, but more pronounced than, that observed with A3+B3 channels (compare [Figs. 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}): K~1/2~ cGMP for activation of A3-613X channels increased from 12.9 ± 3.3 µM (*n* = 11) to 47.4 ± 7.2 µM after PIP~3~ (*n* = 7) and to 46.9 ± 10.2 µM after PIP~2~ (*n* = 4). Because the N-terminal domain of CNG channels is considered one of the critical regions tuning channel sensitivity to cyclic nucleotides ([@bib28]; [@bib23]; [@bib55]) and has been shown previously (for CNGA2 and CNGA3) to bind PIP~3~ in vitro ([@bib6]), we engineered homomeric CNGA3 channels with both N- and C-terminal deletions. We found that the PIP~3~-dependent change in K~1/2~ observed with A3-613X channels was eliminated by complete N-terminal deletion (A3 ΔN \[2--156\], 613X). Moreover, a smaller deletion within the N-terminal region (A3 ΔN \[51--107\], 613X), which prevented PIP~3~ binding in vitro ([@bib6]), similarly eliminated the change of K~1/2~ cGMP after PIP~3~ application to the channels ([Fig. 4, B and C](#fig4){ref-type="fig"}).

![N-terminal region of CNGA3 can confer a PIP~n~-dependent change in apparent cGMP affinity after C-terminal truncation. (A) Subunit diagram and sequence alignment of the N-terminal region of human CNGA3 and rat CNGA2 subunits. The residues highlighted in yellow are conserved arginines in this region of the channel. P99 and A105 of CNGA3, and the corresponding L97 and P103 of CNGA2, are in red. Bold nucleotides indicate residues in human A3 that were mutated in our study as well as related residues in the paralogous rat A2. (B) Representative cGMP concentration--response plots for activation of four different homomeric CNGA3 channels before and after 1 µM PIP~3~: C-terminal deleted (A3-613X), combined N and C deletions (A3ΔN (51--107), 613X), N-terminal charge neutralizations (R72A, R75A, R81A, R82A, R86A, R101A, R103A) combined with C-terminal truncation (A3-N7R-A, 613X), or P99L, A105P (PA-LP) mutations. Currents were measured at +80 mV and were normalized to the maximum current elicited by a saturating concentration of cGMP. Continuous curves represent fits of the cGMP concentration--response relationship with the Hill equation. Hill parameters of the representative patches were as follows. For A3-613X, K~1/2~ = 14.7 µM, *h* = 1.55 before PIP~3~; K~1/2~ = 50.9 µM, *h* = 1.4 after PIP~3~. For A3 PA-LP, K~1/2~ = 5.7 µM, *h* = 1.7 before PIP~3~; K~1/2~ = 11.4 µM, *h* = 1.7 after PIP~3~. (C) Summary of PIP~3~-dependent changes in K~1/2~ cGMP for CNGA3 channels having the specific deletions and/or mutations shown; \*, P \< 0.05 compared with wild-type A3. (D) N-terminal domain of CNGA3 was expressed as a GST fusion protein and tested for PIP~3~ binding in vitro by using PIP~3~-agarose beads. A3N, N-terminal region (amino acids 1--164) of human CNGA3; A3N7R-A, seven arginines were neutralized to alanines within the N-terminal region; A3NΔ51-107, N-terminal region with amino acids 51--107 deleted. Molecular weight markers (in kilodaltons) are shown on the left. Data are representative of four independent experiments. (E) Deletions or charge neutralizations within the N-terminal region of CNGA3, A3 ΔN(2--156) or A3 N7R-A attenuated but did not eliminate the PIP~3~-induced increase in relative cAMP efficacy (I~max~ cAMP/cGMP), whereas P99L, L105P (PA-LA) mutations in the N-terminal region eliminated this increase; \*, P \< 0.05 compared with wild-type A3. The broken horizontal lines refer to a ratio of one, equivalent to no change in the parameter after PIP~n~ application. Error bars indicate mean ± SEM.](JGP_201210944_Fig4){#fig4}

We next asked whether conserved, positively-charged residues contribute to the N-terminal component for regulation of CNGA3 by phosphoinositides. When clusters of arginines in this region were neutralized (N7R-A: R72A, R75A, R81A, R82A, R86A, R101A, R103A), the PIP~3~-induced decrease in apparent cGMP affinity observed for A3-613X channels was abolished ([Fig. 4, B and C](#fig4){ref-type="fig"}). For A3 N7R-A 613X, even application of a 10-fold higher concentration of PIP~3~ (10 µM) produced no significant increase in K~1/2~ cGMP (fold change after PIP~3~ was 1.02 ± 0.05, *n* = 4; P = 0.887 compared with before PIP~3~). Neutralization of the arginine cluster more distal to the transmembrane region (N5R-A) was sufficient to eliminate the decrease in apparent cGMP affinity after PIP~3~, but neutralizing the more proximal two arginines (N2R-A) produced channels that were not significantly different from A3-613X channels. Consistent with our previous work ([@bib6]), an in vitro PIP~3~ binding assay demonstrated that the N-terminal fragment of CNGA3 (A3N) was able to directly bind PIP~3~; charge neutralizations in this region (A3N7R-A) attenuated binding to PIP~3~ beads ([Fig. 4 D](#fig4){ref-type="fig"}), in parallel with their effects on PIP~3~ regulation of channel cGMP sensitivity ([Fig. 4, B and C](#fig4){ref-type="fig"}). Together, these experiments suggest that in intact CNGA3 homomeric channels, a phosphoinositide-regulation module within the N-terminal cytoplasmic region is silent. However, when the distal C terminus of CNGA3 is deleted, this regulation module becomes functionally active, triggering a large decrease in apparent cGMP affinity for homomeric CNGA3 channels once PIP~3~ or PIP~2~ is bound.

The N-terminal region of human CNGA3 subunits previously has been shown to have a CaM binding site that is functionally silent ([@bib29]; [@bib58]); this CaM-binding site overlaps with the region containing the putative N-terminal PIP~3~-binding site (N5R) described here ([Fig. 4 A](#fig4){ref-type="fig"}). [@bib29] have shown previously that changing specific residues within the N-terminal domain of CNGA3, outside of the CaM-binding site, to those present in CNGA2 can unmask Ca^2+^-CaM regulation of homomeric CNGA3 channels. Two key changes, P99L and A105P ([@bib29]), are also present in CaM-sensitive chicken CNGA3 subunits ([@bib4]), but not in CaM-insensitive CNGA3 subunits from other species. Consequently, we tested the idea that P99L and A105P mutations (PA-LP) might also unmask the phosphoinositide sensitivity of CNGA3 homomeric channels. As expected, the basal apparent cGMP affinity was increased for PA-LP channels compared with wild-type CNGA3 ([Table 1](#tbl1){ref-type="table"}). Similar to A3-613X, A3 PA-LP channels demonstrated a significant increase in K~1/2~ cGMP after PIP~3~ or PIP~2~ application (see [Fig. 7, B and C](#fig7){ref-type="fig"}). Hill parameters for PIP~n~ modulation of CNGA3 PA-LP channels were as follows: K~1/2~ = 5.3 ± 0.2 µM, *h* = 2 before PIP~n~; K~1/2~ = 9.4 ± 0.9 µM, *h* = 1.8 after PIP~3~ (*n* = 7); and K~1/2~ = 8.7 ± 0.4 µM, *h* = 1.7 after PIP~2~ (*n* = 4). Likewise, A3-613X channels exhibited enhanced sensitivity to regulation by Ca^2+^-CaM, demonstrating an approximately twofold increase (1.98 ± 0.20, *n* = 7) in K~1/2~ cGMP after application of Ca^2+^-CaM (P \< 0.01, compared with wild-type CNGA3). Together, these results raise the possibility that interdomain coupling between N- and C-terminal regions may control the regulatory competency of the N-terminal domain of CNGA3, which can mediate the effects of CaM or phosphoinositides on channel activity.

Next we investigated whether the N-terminal domain of CNGA3 might influence the increase in cAMP efficacy with PIP~n~ that depends on structural features within the C-terminal region (the C-terminal regulatory module). CNGA3 N-terminal deletion (Δ2-156), or charge neutralizations within the critical N-terminal region (N7R-A) significantly reduced but did not eliminate the increase in cAMP efficacy with PIP~3~ ([Fig. 4 E](#fig4){ref-type="fig"}). This indicates that the C-terminal component of PIP~n~ sensitivity does not require an intact N-terminal regulatory module. However, P99L and A105P mutations (PA-LP) within the N-terminal region of CNGA3 eliminated the effect of PIP~3~ on cAMP efficacy ([Fig. 4 E](#fig4){ref-type="fig"}). Collectively, the results show that CNGA3 subunits present separable N and C regulatory modules supporting different types of sensitivity to PIP~n~: a decrease in apparent cGMP affinity (the N component) or an increase in partial agonist efficacy (the C component). Each independent regulatory module can function in the absence of structural features necessary for action of the other module. Conversely, changes in the N or C domains (e.g., PA-LP or 613X, respectively) can dramatically tune the reciprocal regulatory component.

Both N- and C-terminal cytoplasmic regions of CNGA3 contribute to PIP~n~ regulation of heteromeric CNGA3+CNGB3 channels
-----------------------------------------------------------------------------------------------------------------------

The apparent cGMP affinity of heteromeric CNGA3+CNGB3 channels is sensitive to regulation by PIP~n~ ([@bib7]). We found that 1 µM PIP~3~ or 10 µM PIP~2~ attenuated the currents elicited by application of 5 µM cGMP ([Fig. 5 A](#fig5){ref-type="fig"}), a subsaturating concentration of cGMP that approximates the dark steady-state level in vertebrate photoreceptors ([@bib61]; [@bib17]). As previously described, cGMP dose--response relationships for activation of the heteromeric channels show that application of 1 µM PIP~3~ shifted the K~1/2~ cGMP ∼1.5-fold to a higher concentration of ligand ([Fig. 5 B](#fig5){ref-type="fig"}, left; [@bib7]). We found that higher concentrations of PIP~2~ (10 µM) were able to produce a similar shift in the apparent affinity for cGMP ([Fig. 5 B](#fig5){ref-type="fig"}, right). The mean Hill parameters for PIP~n~ modulation of A3+B3 channels were as follows: K~1/2~ = 13.5 ± 0.6 µM, *h* = 1.9 before PIP~n~ (*n* = 18); K~1/2~ = 20.8 ± 1.4 µM, *h* = 1.6 after PIP~3~ (*n* = 9); or K~1/2~ = 23.4 ± 1.8 µM, *h* = 1.6 after PIP~2~ (*n* = 9). At these concentrations of PIP~3~ or PIP~2~, we observed only a small decrease in the current at a saturating concentration of cGMP: I~max~ cGMP was 95.4 ± 2.8% (*n* = 9) after 1 µM PIP~3~ and 85.3 ± 3.7% (*n* = 6) after 10 µM PIP~2~ compared with initial values. [Fig. 5 C](#fig5){ref-type="fig"} shows the concentration--response relationship for the percent increase in K~1/2~ cGMP produced by various concentrations of PIP~3~, PIP~2~, or natural PIP~2~ applied to patches expressing heteromeric CNGA3+CNGB3 channels. These results indicate that A3+B3 channels may exhibit somewhat greater sensitivity to regulation by PIP~3~ compared with PIP~2~.

![Heteromeric CNGA3+CNGB3 channels are inhibited by PIP~3~ or PIP~2~. (A) Representative current traces for heteromeric CNGA3+CNGB3 channels, elicited by subsaturating concentrations of cGMP (5 µM), before (black) and after (red) 1 µM PIP~3~ or 10 µM PIP~2~ application for ∼5 min. (B) Representative dose--response relationships for the activation of heteromeric CNGA3+CNGB3 channels by cGMP before and after PIP~3~ or PIP~2~ application. The shadings indicate the approximate physiological range of intracellular cGMP levels within vertebrate photoreceptors in the dark. The Hill parameters for each representative patch were: K~1/2~ cGMP = 16.1 µM, *h* = 2.05 before PIP~3~; K~1/2~ cGMP = 26.5 µM, *h* = 2.0 after PIP~3~; K~1/2~ cGMP = 12.8 µM, *h* = 1.8 before PIP~2~; and K~1/2~ cGMP = 24.5 µM, *h* = 1.6 after PIP~2~. (C) Plot of percentage increase in K~1/2~ cGMP for heteromeric A3+B3 channels at different concentrations of PIP~3~ (closed squares), PIP~2~ (closed circles), and natural PIP~2~ (open circles; *n* = 4--5 for each PIP~n~ concentration). The PIP~n~ concentration--response relationships were fitted with the Hill equation, and the Hill parameters (K~1/2~ and *h*) for each phosphoinositide species were as follows: 0.58 µM and 1.4 for PIP~3~ (diC8-PIP~3~), 3.44 µM and 1.5 for PIP~2~ (diC8-PIP~2~), and 2.84 µM and 1.4 for natural PIP~2~. Error bars indicate mean ± SEM.](JGP_201210944_Fig5){#fig5}

To determine whether the structural features necessary for regulation of homomeric CNGA3 channels by phosphoinositides are also important for regulation of heteromeric CNG channels, we tested the effects of CNGA3 mutations and/or deletions on the PIP~3~ and PIP~2~ sensitivity of A3+B3 channels. For all subunit combinations, the formation of functional heteromeric channels at the plasma membrane were confirmed by sensitivity to block by [l]{.smallcaps}-cis-diltiazem, which serves as a reporter for incorporation of CNGB3 subunits into functional CNG channels ([@bib22]; [@bib59]). Charge neutralizations within the critical N-terminal region of CNGA3 (N7R-A) significantly reduced but did not eliminate the reduction in apparent cGMP affinity by PIP~3~ or PIP~2~ for heteromeric CNGA3+CNGB3 channels ([Fig. 6 B](#fig6){ref-type="fig"}). Similarly, charge neutralizations in the C-terminal region of CNGA3 (RR-QQ) significantly reduced but did not eliminate the reduction in apparent cGMP affinity with PIP~3~ or PIP~2~ for heteromeric channels ([Fig. 6 B](#fig6){ref-type="fig"}). However, combining mutations in the N-terminal region (N7R-A) with mutations in the C-terminal region of CNGA3 (RR-QQ), each of which eliminated the respective N- and C-terminal components of PIP~n~ regulation for homomeric CNGA3 channels, gave rise to heteromeric channels that were insensitive to regulation by 10 µM PIP~2~ or 1 µM PIP~3~ ([Fig. 6, A and B](#fig6){ref-type="fig"}; *t* test for the effects of PIP~n~ on A3-N7R-A,RR-QQ+B3 channels; P = 0.618 for PIP~2~ and P = 0.896 for PIP~3~). For A3-N7R-A,RR-QQ+B3 channels, a 10-fold higher concentration of PIP~3~ (10 µM) still produced no significant increase in K~1/2~ cGMP (the percent change caused by PIP~3~ was 2 ± 8%, *n* = 5; P = 0.930 compared with before PIP~3~). These results indicate that both N- and C-terminal regions of CNGA3 contribute to PIP~n~ regulation of heteromeric CNGA3+CNGB3 channels.

![Both N- and C-terminal regions of CNGA3 subunits are important for modulation of heteromeric CNGA3+CNGB3 channels by PIP~3~ or PIP~2~. (A) Representative cGMP concentration--response plot showing the effect of 10 µM PIP~2~ on A3+B3 heteromeric channels having N- (N7R-A) and C-terminal (RR-QQ) charge neutralizations within CNGA3. (B) Effects of PIP~3~ (1 µM) and PIP~2~ (10 µM) on heteromeric A3+B3 channels having specified mutations in A3 subunits. \*, P \< 0.05; \*\*, P \< 0.001 compared with wild-type A3+B3 for both PIP~3~ and PIP~2~. In the pairwise comparisons, statistically significant differences (P \< 0.05) were also detected between A3N7R-A+B3 or A3 RR-QQ+B3 versus A3 N7R-A, RR-QQ+B3 channels. (C) Representative cGMP concentration--response relationship for activation of A2ΔN+B3 channels before (black) and after 1 µM PIP~3~ (red). (D) Percentage change in K~1/2~ cGMP after PIP~3~ (1 µM) for various CNG channel subunit compositions. A2ΔN ([@bib6]), A2ΔN+B1, A2ΔN+B3 channels showed no sensitivity to PIP~3~, whereas PIP~3~ produced a statistically significant increase in K~1/2~ cGMP for A1+B3 (*n* = 4), A2+B3 (*n* = 3), and A3+B1 (*n* = 4) channels compared with A2ΔN+B3 or A2ΔN+B1 channels (\*, P \< 0.05). Error bars indicate mean ± SEM.](JGP_201210944_Fig6){#fig6}

A corollary to the results shown in [Fig. 6 (A and B)](#fig6){ref-type="fig"} is the implication that CNGB3 subunits cannot support PIP~n~ sensitivity in the absence of functional PIP~n~-regulation modules in CNGA3. To further investigate this implication, we coexpressed CNGB3 subunits with CNGA1 or CNGA2 subunits. CNGA2-containing (olfactory) CNG channels previously have been shown to be sensitive to PIP~3~ regulation ([@bib71]; [@bib85]; [@bib6]); deletion of amino acids 61--90 within the N-terminal region of CNGA2 generated homomeric A2 channels and heteromeric A2/B1b/A4 channels that were insensitive to PIP~3~ ([@bib6]). To isolate the possible influence of the CNGA3 subunit on PIP~n~ sensitivity of heteromeric channels, we used PIP~n~-insensitive CNGA2 subunits with the 61--90 deletion (A2ΔN). We found that A2ΔN+B3 and A2ΔN+B1 channels were both insensitive to regulation by PIP~3~. ([Fig. 6, C and D](#fig6){ref-type="fig"}). In contrast, coexpression of wild-type CNGA2 with CNGB3, CNGA1 with CNGB3, or CNGA3 with CNGB1 all formed PIP~3~-sensitive channels ([Fig. 6 D](#fig6){ref-type="fig"}). Furthermore, CNGB3 subunits with extensive N- and C-terminal truncations (Δ2-205; Δ669-809), and/or charge-neutralizing mutations in other potential PIP~n~-binding sites located in the S2-S3 loop, S4-S5 loop, or C-linker cytoplasmic regions of CNGB3, all preserved the PIP~n~ sensitivity of A3+B3 channels ([Fig. S3](http://www.jgp.org/cgi/content/full/jgp.201210944/DC1){#supp3}). Overall, these results suggest that regulation of photoreceptor CNG channels by phosphoinositides is subunit specific: CNGA3 or CNGA1 subunits, but not CNGB3 or CNGB1 subunits, appear to confer PIP~n~ sensitivity upon heteromeric channels.

Intersubunit N--C interactions control regulation of cone CNGA3 channels by phosphoinositides
---------------------------------------------------------------------------------------------

The results described here suggest that the C-terminal domain of CNGA3 can restrict an N-terminal component of PIP~n~ sensitivity; when the C-terminal domain was truncated (613X), then a robust change in K~1/2~ cGMP after PIP~n~ application was revealed ([Fig. 4, B and C](#fig4){ref-type="fig"}). Similarly, mutations or deletions in the N-terminal domain of CNGA3 influenced the C-terminal component of PIP~n~ sensitivity ([Fig. 4 E](#fig4){ref-type="fig"}). Based on these observations, we hypothesized that interdomain N--C interactions involving CNGA3 subunits control the PIP~n~ sensitivity of cone CNG channels. Therefore, we sought to determine whether the coupling between N- and C-terminal regions that appears to regulate PIP~n~ sensitivity occurs only within the same subunit (intrasubunit) or between channel subunits (intersubunit). To address this question, we coexpressed CNGA3 subunits with distinct changes that each individually eliminated the increase in cAMP efficacy with PIP~n~ application (the C-terminal component of PIP~n~ sensitivity): one subunit with PA-LP mutations in the N-terminal region and one subunit with RR-QQ mutations in the C-terminal region. If the N-terminal PA-LP mutations silenced the C-terminal component of PIP~n~ sensitivity only within the same subunit (intrasubunit interaction), then the combination of these two insensitive subunits would produce a mixture of channels that remain insensitive to PIP~3~. Conversely, if the N-terminal PA-LP mutations exerted an effect on the adjacent subunit (intersubunit interaction), then the mixture of channels formed by the combination of these subunits would produce some level of regulation of cAMP efficacy by PIP~3~. In this scenario, regulation would be supported by complementary subunits via interaction of the normal N-terminal domain of RR-QQ subunits with the normal C-terminal domain of PA-LP subunits. For PA-LP+RR-QQ channels, we observed a small but significant increase in cAMP efficacy with PIP~3~ compared with homomeric PA-LP and homomeric RR-QQ channels ([Fig. 7 A](#fig7){ref-type="fig"}). Assuming random subunit assembly and a binomial distribution of channel species, under these conditions the expected mean number of favorable intersubunit N--C interactions is only about one per channel (out of four possible). This outcome is consistent with an intersubunit N--C interaction for CNGA3 that regulates the C-terminal component of PIP~3~ sensitivity.

![Intersubunit N--C coupling controls phosphoinositide sensitivity of CNGA3 channels. (A) Coexpression of PA-LA subunits with RR-QQ subunits, both of which individually form channels insensitive to 1 µM PIP~3~ regarding cAMP efficacy, generated channels that were sensitive to PIP~3~. The I~max~ cAMP/cGMP (PIP~3~/control) for coexpression of A3 PA-LA with A3 RR-QQ was 1.67 ± 0.06 (*n* = 6, P \< 0.001). (B) Coexpression of A3 wild type (WT) and A3 N7R-A,613X subunits generated channels that exhibited an increased K~1/2~ cGMP after 1 µM PIP~3~ application. Channels formed by A3 WT//A3 N7R-A,613X tandem dimers exhibited enhanced sensitivity to PIP~3~-induced inhibition of apparent cGMP affinity. Ratio K~1/2~ cGMP (PIP~3~/control) was significantly greater for A3//A3 N7R-A,613X dimers (*n* = 4) compared with channels formed by coexpression of A3 with A3-N7R-A,613X (*n* = 8; P \< 0.05). The broken horizontal lines refer to a ratio of one, equivalent to no change in the parameter after PIP~n~ application. Error bars indicate mean ± SEM.](JGP_201210944_Fig7){#fig7}

We applied a similar approach to gain insight into how putative N--C coupling might control the N-terminal component of PIP~n~ sensitivity. As described in [Fig. 4](#fig4){ref-type="fig"}, the C-terminal truncation (613X) in CNGA3 unmasked the N-terminal component of PIP~n~ sensitivity, manifested as a large change in K~1/2~ cGMP; charge neutralizations within the N-terminal region of CNGA3 (N7R-A) eliminated the PIP~n~ sensitivity of 613X channels. If the 613X truncation activates the N-terminal component of PIP~n~ sensitivity only within the same subunit (intrasubunit), then combining insensitive wild-type CNGA3 subunits with insensitive N7R-A,613X subunits would produce channels that remain insensitive to phosphoinositides. Conversely, if the 613X truncation activates the N-terminal regulatory component of an adjacent subunit (intersubunit), then the assembly of A3 wild-type subunits with N7R-A,613X subunits would be expected to produce some channels that exhibit a change in K~1/2~ cGMP after PIP~3~ application. Because the 613X truncation reduced channel expression levels and is expected to impair channel assembly ([@bib91], [@bib92]; [@bib70]), we injected a 5:1 ratio of N7R-A,613X to wild-type A3 cRNA into oocytes. Coexpression of N7R-A,613X with wild-type A3 produced channels exhibiting a small but significant increase in K~1/2~ cGMP after PIP~3~ ([Fig. 7 B](#fig7){ref-type="fig"}), which is consistent with an intersubunit interaction controlling the N-terminal component of PIP~n~ sensitivity.

To verify this finding, we more precisely controlled channel subunit arrangement by engineering concatenated cDNA constructs to produce tandem dimers of wild-type and N7R-A,613X subunits ([Fig. 7 B](#fig7){ref-type="fig"}). The tandem-dimer configuration of wild-type subunits (A3//A3) by itself did not enhance PIP~3~ sensitivity. As expected, expression of tandem-dimer constructs encoding alternating head-to-tail assemblies of wild-type and N7R-A,613X subunits generated a more robust increase in K~1/2~ cGMP after PIP~3~ compared with random assembly of the respective subunits ([Fig. 7 B](#fig7){ref-type="fig"}). The fixed arrangement of subunits with tandem A3//N7R-A,613X heterodimer expression ([Fig. 8](#fig8){ref-type="fig"}, iv) is expected to produce two favorable intersubunit N--C interactions per channel (out of four possible), compared with a mean of about one favorable intersubunit N--C interaction per channel with random assembly of wild-type A3 and N7R-A,613X monomers. In agreement with the predicted stoichiometry of favorable N--C interactions for tandem A3//N7R-A,613X heterodimers, the magnitude of the change in the energetics of channel opening produced by PIP~3~ (ΔΔG) was 1.29 ± 0.08 kcal/mol, approximately half that of 613X homomeric channels (2.64 ± 0.26 kcal/mol). Overall, these results are consistent with the existence of intersubunit N--C interactions that control the two components of PIP~n~ sensitivity (N and C) in channels containing CNGA3 subunits ([Fig. 8](#fig8){ref-type="fig"}). Because assembly with CNGB3 subunits by necessity alters some of these N--C interactions via substitution (of B3 cytoplasmic domains for some A3 cytoplasmic domains), we propose a model where CNGB3 tunes the regulatory features of CNGA3 ([Fig. 8](#fig8){ref-type="fig"}, v), producing heteromeric channels that exhibit a change in K~1/2~ cGMP with changes in PIP~3~ or PIP~2~ levels.

![Model for tuning phosphoinositide sensitivity of cone CNG channels via intersubunit interactions. Six scenarios here illustrate how proposed N--C interactions between channel subunits may control PIP~n~ regulation. Two regulatory modules are located within the N- and C-terminal regions of CNGA3 subunits, respectively. These PIP~n~-regulation modules can be silenced (red) or activated (green) due to changes in intersubunit interactions. (i) One component involves the C-terminal region of CNGA3, which is necessary for a PIP~n~-dependent increase in cAMP efficacy. (ii and v) The other component, manifested as a decrease in apparent cGMP affinity, requires the N-terminal region of CNGA3 and is unmasked either by deletion of the C-terminal region (ii) or by assembly with CNGB3 subunits (v). (iii) PA-LP mutations in CNGA3 also alter N--C coupling, thereby activating the N module and silencing the C module. (iv) The PIP~n~-regulation competency of channels formed by A3//A3 N7R-A,613X tandem dimers supports an intersubunit N--C interaction. (vi) In addition, PIP~n~ regulation of heteromeric CNGA3+CNGB3 channels depends on N and C regulatory modules in CNGA3.](JGP_201210944_Fig8){#fig8}

DISCUSSION
==========

Phosphoinositides modulate the function of a wide range of different ion channels, but for many channel types little is known about the underlying molecular mechanisms. In the present study, we have identified features and mechanisms fundamental for phosphoinositide regulation of cone CNG channel ligand sensitivity. For both cone and rod CNG channels, our results show that the A subunits likely represent the principal subunits supporting PIP~n~ regulation, whereas the B subunits are not sufficient to confer regulation when combined with PIP~n~-insensitive A subunits. This interpretation applies also to olfactory CNG channels, where the A2 subunits support PIP~n~ regulation, but A4 and B1b subunits do not ([@bib6]). Channels formed by CNGA3 subunits exhibit two separable components for regulation of channel gating by PIP~2~ or PIP~3~, which is reminiscent of the dual effect of PIP~2~ regulation of several other related channels ([@bib18]; [@bib66]; [@bib1]). First, cAMP efficacy for homomeric CNGA3 channels is enhanced by phosphoinositides and reduced by application of poly-lysine. This component depends on structural features located in the C-terminal region after the CNBD, and is influenced by a critical ligand discrimination residue in the CNBD. Binding of PIP~3~ or PIP~2~ to the channel, or to a channel-associated protein, may facilitate the ability of the CNBD to accommodate the partial agonist cAMP (or cGMP for D609M channels) during channel activation. A second component is mediated by the N-terminal region of CNGA3, which can confer a decrease in apparent cGMP affinity when combined with C-terminal truncation or assembly with CNGB3 subunits. Neutralization of conserved positively charged residues in each region eliminated each component of phosphoinositide sensitivity. Furthermore, both N- and C-terminal regions contribute to phosphoinositide regulation of heteromeric CNGA3+CNGB3 channels. However, in the context of heteromeric channels, the C-terminal component supports a change in K~1/2~ cGMP rather than a change in cAMP efficacy. In addition, PIP~n~ effects on cone CNG channel gating were relatively stable, reversing slowly during washout, but reversal was accelerated by poly-lysine.

The two regions in CNGA3 shown here to be critical for PIP~n~ regulation may represent direct PIP~n~ binding sites, or, alternatively, be essential for communicating PIP~n~ binding elsewhere into changes in channel gating, thus stabilizing the closed state relative to the open state of the channel. If one or both of these regions provide direct binding sites for phosphoinositides, the lack of pronounced PIP~n~ specificity and the loss of PIP~n~ sensitivity with CNGA3 positive-charge neutralizations are both consistent with electrostatic interactions between the channel and phosphoinositides. Mutations in CNGA3 that eliminated components of PIP~n~ regulation are unlikely to arise from a generalized allosteric destabilization of PIP~n~ binding, as none of the changes dramatically altered channel gating in the absence of phosphoinositides ([Table 1](#tbl1){ref-type="table"}). The lack of response to PIP~n~ for these mutations could arise from a change in PIP~n~ efficacy, a large decrease in sensitivity to PIP~n~, or both. The CNGA3 N-terminal regulatory module is homologous to the overlapping CaM and putative PIP~3~ binding site present in the N-terminal region of CNGA2 subunits ([@bib29]; [@bib6]). Consistent with previous studies showing that mutations outside the functionally silent, N-terminal CaM-binding site in CNGA3 can unmask CaM sensitivity ([@bib29]), similar mutations (PA-LP) in CNGA3 also unmask PIP~n~ sensitivity. We propose that these mutations activate the N-terminal regulatory module of CNGA3 by altering coupling between N- and C-terminal domains of the channel.

The C-terminal component of PIP~n~ sensitivity appears to be unique to CNGA3 channels: it is not observed with either CNGA1 or CNGA2 homomeric channels, despite extensive sequence homology in the post-CNBD region. Our results are in several ways consistent with the simple scenario where the C-terminal region of CNGA3 provides a binding site for PIP~2~ or PIP~3~, as channel regulation and in vitro phosphoinositide binding are both disrupted by mutations of conserved positively charged residues. Conversely, likely structural constraints for the C-terminal domain make mechanisms that involve direct PIP~n~ binding seem less plausible for the C-terminal regulatory module compared with the N-terminal regulatory module. First, structures of related C-terminal fragments from HCN channels having homologous cyclic nucleotide-binding domains ([@bib84]; [@bib19]) suggest that the post-CNBD region is distant from the plasma membrane, which seemingly precludes direct interactions with phosphoinositides. However, these structures present a static picture of the homologous C-terminal region that may not represent all possible configurations. For example, a putative PIP~2~-binding site in the distal post-CNBD region of HERG channels has been identified ([@bib3]). Second, the post-CNBD region of CNGA3 is thought to form homotypic interactions via a C-terminal leucine zipper (CLZ; [@bib91]). These interactions are proposed to help control subunit assembly ([@bib91], [@bib92]; [@bib70]). It is not known if the CLZ coiled-coil bundle is a static or dynamic arrangement, but it could potentially restrict this region from direct interactions with phosphoinositides in the plasma membrane.

Instead, we favor an indirect mechanism for the C-terminal component of PIP~n~ sensitivity, where the region between amino acids 635 and 655 of CNGA3 is necessary to translate PIP~n~ binding---to a different site in CNGA3 or to a channel-associated protein---into a conformational change that modifies channel gating. It appears unlikely that the N-terminal regulatory module of CNGA3 represents that site, or that a combined "clamshell" phosphoinositide-binding site is formed by parts of the N- and C-terminal cytoplasmic domains of CNGA3. Note that CNGA3 N-terminal deletion, or N-terminal charge neutralizations, both leave intact the C-terminal component of PIP~n~ regulation. Also, CNGA3 635X lacks the C-terminal component, yet still masks the N-terminal component of PIP~n~ regulation in these channels. Instead, the results are consistent with the presence of two separable regulatory modules. Potential channel-interacting proteins that might indirectly mediate the C-terminal component of PIP~n~ regulation include Grb14, which has been shown recently to interact with the post-CNBD region of CNGA1 ([@bib31]). Grb14 processes a pleckstrin homology domain, and Grb14-PIP~3~ complexes have been detected in retinal lysates after insulin stimulation ([@bib63]). Also, an unspecified tyrosine kinase is thought to directly associate with rod and cone photoreceptor CNG channels ([@bib54]; [@bib9]). In addition, localization of rod photoreceptor CNG channels has been shown to depend on interactions with elements of the cytoskeleton, including ankyrin G ([@bib41]). For NMDA receptors and TRPC4α channels, interaction with the actin cytoskeleton is necessary for PIP~2~ regulation of channel function ([@bib52]; [@bib57]). However, we found that actin cytoskeleton disruption did not prevent the PIP~n~-dependent increase in cAMP efficacy for CNGA3 channels (Fig. S2). Another possible alternative PIP~n~ binding site not examined in the present study is the C-linker region of CNGA3. For related SpIH channels, one component of PIP~2~ regulation depends on positively charged residues in the A′ helix of the C-linker region ([@bib18]). Related to this possibility, we have shown previously that in vitro CaM binding to the C-linker region of CNGA4 subunits is blocked by prior application of PIP~3~ ([@bib6]).

Our results suggest that intersubunit coupling involving N- and C-terminal cytoplasmic regions of CNGA3 helps control channel sensitivity to PIP~n~ regulation. Interdomain N--C interactions are characteristic of CNG channels and have been shown previously to be important for channel assembly, gating, and/or regulation ([@bib27]; [@bib78]; [@bib67]; [@bib75]; [@bib89]; [@bib53]). We propose a model where intersubunit interactions control the competency of the respective regulatory modules present in the N- and C-terminal regions of CNGA3. Assembly of CNGB3 with CNGA3 subunits alters some of these interactions, thereby tuning the phosphoinositide sensitivity of the channels. Similarly, regulation of channel gating by N--C interactions has been described recently for related HERG channels, including a proposed interaction between the N-terminal domain and the homologous CNBD of HERG ([@bib32]; [@bib56]). In addition to CLZ interactions among C-terminal domains, CNG channels are thought to make intersubunit contacts between C-linker regions of adjacent subunits similar to those present in related HCN channels ([@bib12]; [@bib14]). For cone CNG channels, the precise intersubunit contacts and physical mechanisms responsible for N--C coupling related to PIP~n~ regulation remain to be determined.

The physiological impact of phosphoinositide regulation on photoreceptor CNG channel function is not well understood. For olfactory receptor neurons, PI3K activity has been shown to modulate odorant signaling, in part via PIP~3~-dependent regulation of olfactory CNG channel ligand sensitivity ([@bib71]; [@bib85]; [@bib6]; [@bib77]). Some evidence indicates that photoreceptor phosphoinositide concentrations change under light, circadian, and paracrine control, and that these changes may influence photoreceptor function and health. Enzymes involved in PIP~n~ synthesis/metabolism are known to be located in the photoreceptor outer segment. For example, PI3K activity has recently been shown to contribute to rod photoreceptor function ([@bib38]) and to be essential for cone photoreceptor viability ([@bib39]). Light, insulin receptor activation, and tyrosine phosphorylation of outer segment proteins can regulate the plasma-membrane localization and activity of PIP~n~ kinases ([@bib30]; [@bib62]; [@bib37]; [@bib38]). A robust increase in outer segment PIP~3~ levels after light exposure has been reported via GFP-tagged Akt1-PH domain localization in transgenic rod photoreceptors ([@bib47]). In addition to potential neuroprotective effects, local production or metabolism of phosphoinositides may contribute to modulation of phototransduction ([@bib82]; [@bib33]). Furthermore, PI3K activity has also been demonstrated to play a role in circadian outputs in photoreceptors ([@bib44]). Changes in PIP~2~ levels also may be critical for paracrine signaling pathways: somatostatin receptors in avian cone photoreceptors have been linked to a transient increase in CNG channel ligand sensitivity that depends on the phospholipase C activation ([@bib10]). Finally, intracellular calcium concentration has been shown to be both an input and an output signal for changes in phosphoinositide levels ([@bib21]), including, for example, Ca^2+^-dependent stimulation of PIP~2~ synthesis via neuronal calcium sensor-1 (NCS-1; [@bib86]; [@bib90]; [@bib81]). We speculate that PIP~n~ regulation may contribute to adjustments of CNG channel ligand sensitivity on a slow time scale (via paracrine or circadian inputs) and possibly on a faster time scale via light- and/or calcium-dependent changes in phosphoinositide metabolism.
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